as on October 27, 2025 at 1:03 pm IST
Day's Low
Day's High
7.10%
Downside
0.15%
Upside
52 Week's Low
52 Week's High
27.60%
Downside
62.28%
Upside
as on October 27, 2025 at 1:03 pm IST
Market Cap
₹66.21 Cr
Return on Equity (ROE)
16.88
PE Ratio (TTM)
27.61
Return on capital employed (ROCE)
11.71
Industry PE ratio
53.25
Beta (LTM)
0.36
P/B Ratio
12.04
Dividend Yield
0PEG Ratio
7.96
Quarterly Earnings Growth YOY
740
EPS (TTM)
1.97
Sector
Healthcare
Book Value
7.03
Technical Analysis
Bullish
View Technical Analysis
as on October 27, 2025 at 1:03 pm IST
Aspira Pathlab & Diagnostics Ltd in the last 5 years
Lowest (-433.33x)
November 29, 2024
Today (27.61x)
October 24, 2025
Industry (53.25x)
October 24, 2025
Highest (124.02x)
March 24, 2025
Today’s Price to Earnings Ratio: 27.61x
Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab & Diagnostics Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 66.21 | 41.27% | 0.58 | 2 | 22 | |
| NA | 1,162.74 | 51.83% | 0.00 | 21 | 231 | |
| BUY | 10,163.61 | 11.91% | 0.65 | 143 | 704 | |
| NA | 4,541.75 | 61.16% | 0.51 | -161 | 6 | |
| HOLD | 12,971.14 | -1.08% | 0.53 | 406 | 2,839 |
Search interest for Aspira Pathlab & Diagnostics Ltd Stock has increased by 184% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:184% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aspira Pathlab & Diagnostics Ltd.
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, Aspira Pathlab stock has moved up by 28.3%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 81.61% of holdings in Jun 2025 quarter
Against Peers
![]()
In the last 1 year, Fortis Healthcare Ltd has given 71.5% return, outperforming this stock by 43.2%
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 280.4% return, outperforming this stock by 238.2%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 18.39% of holdings in Jun 2025 quarter
| Organisation | Aspira Pathlab & Diagnostics Ltd |
| Headquarters | Mumbai |
| Industry | Healthcare |
| CEO | Haseeb Drabu |
| E-voting on shares | Click here to vote |
Aspira Pathlab & Diagnostics Ltd share price today stands at ₹65.8 as on . Aspira Pathlab & Diagnostics Ltd share today touched a day high of ₹65.9 and a low of ₹61.13.
Aspira Pathlab & Diagnostics Ltd touched a 52 week high of ₹106.78 and a 52 week low of ₹47.64. Aspira Pathlab & Diagnostics Ltd share price today i.e. is trending at ₹65.8, which is -38.38% down from its 52 week high and 38.12% up from its 52 week low.
Aspira Pathlab & Diagnostics Ltd market capitalisation is ₹66.21 Cr as on .
To buy Aspira Pathlab & Diagnostics Ltd shares, you need to follow these steps:
Aspira Pathlab & Diagnostics Ltd trading volume is 6,002.00 as on . This means that 6,002.00 shares of Aspira Pathlab & Diagnostics Ltd were bought and sold on the stock market during today's trading session.